Assignee
IMCLONE LLC
US12 patents
Top patents by PatentIndex Score
US7598350B2Oct 6, 2009
Human anti-epidermal growth factor receptor antibody
IMCLONE LLC73 citations97
US7972596B2Jul 5, 2011
Antibodies against vascular endothelial growth factor receptor-1
IMCLONE LLC23 citations92
US8043618B2Oct 25, 2011
Fibroblast growth factor receptor-3 (FGFR-3) inhibitors and methods of treatment
IMCLONE LLC14 citations91
US7740850B2Jun 22, 2010
PDGFRβ-specific antibodies
IMCLONE LLC31 citations89
US7638605B2Dec 29, 2009
Fully human antibodies directed against the human insulin-like growth factor-1 receptor
IMCLONE LLC13 citations80
US7947811B2May 24, 2011
Antibodies that bind specifically to human RON protein
IMCLONE LLC14 citations79
US7968093B2Jun 28, 2011
Fully human antibodies directed against the human insulin-like growth factor-1 receptor
IMCLONE LLC3 citations58
US9375488B2Jun 28, 2016
Compounds to fibroblast growth factor receptor-3 (FGFR3) and methods of treatment
IMCLONE LLC2 citations55
US7951370B2May 31, 2011
Anti-TYRP1 antibodies
IMCLONE LLC2 citations54
US7972600B2Jul 5, 2011
IGF-IR antagonists as adjuvants for treatment of prostate cancer
IMCLONE LLC0 citations46
US10766961B2Sep 8, 2020
Anti-VEGFR2 antibody therapy for hepatocellular carcinoma
IMCLONE LLC0 citations39
US8784818B2Jul 22, 2014
Anti-VEGFR-3 antibody compositions
IMCLONE LLC0 citations38